Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-04-26
2011-04-26
Lewis, Patrick T (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S026000
Reexamination Certificate
active
07932233
ABSTRACT:
The present invention concerns the use of tricyclic terpenes chosen from the group consisting of fusicoccin, ophyobolins or cotylenins for the therapy and diagnosis of coagulation-correlated pathologies such as Bernard-Soulier syndrome (BSS), von Willebrand disease (vWD), Glanzmann's thrombasthenia or thrombocytopenia.
REFERENCES:
Biophysical Research Communications (1997), vol. 238, pp. 758-763.
Aducci Patrizia
Camoni Lorenzo
Di Lucente Cristina
Visconti Sabina
Arent & Fox LLP
Lewis Patrick T
Universita'Degli Studi Roma “Tor Vergata”
LandOfFree
Fungal phytotoxin fusicoccin for the treatment and diagnosis... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fungal phytotoxin fusicoccin for the treatment and diagnosis..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fungal phytotoxin fusicoccin for the treatment and diagnosis... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2690225